- Open
- 42.93
- High
- 43.20
- Low
- 42.50
- Close
- 42.50
- Change
- +0.00 (0.00%)
- Volume
- 15,754
| 3 Aug 2026 | 12:15:00 | Liquidity Agreement Update and Total Voting Rights |
| 28 Jul 2026 | 07:00:02 | Half-year trading update |
| 1 Jul 2026 | 16:00:00 | Liquidity Agreement Monthly Update and TVR |
| 30 Jun 2026 | 17:45:00 | Result of AGM |
| 11 Jun 2026 | 07:00:07 | Publication of Annual Report |
Novacyt S.A. is an international molecular diagnostics company that develops, manufactures, and commercializes a range of molecular assays and instrumentation. Its operations are divided into three segments: Clinical, which offers in vitro diagnostic products in reproductive health, precision medicine, and infectious diseases; Instrumentation, which includes DNA sample preparation platforms and PCR machines; and Research Use Only services for the life sciences sector. Novacyt serves customers in human health, animal health, and environmental markets, with a commercial presence in over 65 countries, including significant operations in Europe, North America, and Asia-Pacific.
| 3 Aug 2026 | 12:15:00 | Liquidity Agreement Update and Total Voting Rights |
| 28 Jul 2026 | 07:00:02 | Half-year trading update |
| 1 Jul 2026 | 16:00:00 | Liquidity Agreement Monthly Update and TVR |
| 30 Jun 2026 | 17:45:00 | Result of AGM |
| 11 Jun 2026 | 07:00:07 | Publication of Annual Report |
Novacyt S.A. is an international molecular diagnostics company that develops, manufactures, and commercializes a range of molecular assays and instrumentation. Its operations are divided into three segments: Clinical, which offers in vitro diagnostic products in reproductive health, precision medicine, and infectious diseases; Instrumentation, which includes DNA sample preparation platforms and PCR machines; and Research Use Only services for the life sciences sector. Novacyt serves customers in human health, animal health, and environmental markets, with a commercial presence in over 65 countries, including significant operations in Europe, North America, and Asia-Pacific.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £284m | -0.1% | |
| £66m | -0.2% | |
NCYTNovacyt S.A. | £31m | +0.1% |
| £28m | +1.1% | |
| £14m | +0.8% | |
| £14m | -0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £284m | -0.1% | |
| £66m | -0.2% | |
NCYTNovacyt S.A. | £31m | +0.1% |
| £28m | +1.1% | |
| £14m | +0.8% | |
| £14m | -0.3% |
